top of page
Ziva_logo_teal.png
Connect

A decade of
purpose-led innovation.

Ten years ago, a small team in Perth set out to solve one very specific problem: to give surgeons a way to see what they had, until then, only been able to feel. Ziva has grown into a Tissue Intelligence™ company with the intention to solve this very problem, and beyond.

Ziva’s QME technology — quantitative micro-elastography emerged from a decade of foundational research at UWA and the Harry Perkins Institute, and was translated into a surgical platform through OncoRes' proprietary engineering and development.  An exclusive commercial license and 44 patent families protect the technology, the probe design and the system.

OUR JOURNEY

A decade of
purpose‑led innovation.

What began as a way to read the margins of a breast cancer surgery has evolved into something much more impactful: Tissue Intelligence™. Tissue Intelligence™ using QME technology was developed to assess the tissue directly inside the patient during surgery, helping surgeons decide what to remove and what to preserve.

Explore Tissue Intelligence™
AT the LAb
_N8A0046-1.jpg

WHAT GUIDES US

Our why.

Purpose

We bring light to the invisible, positively impacting people and their families, in the moment it matters most.

Mission

Real-time clarity on what to remove and what to preserve, the first time.

Vision

Life, uninterrupted.

OUR JOURNEY

Our story so far. 

2013

The idea takes root: the technology behind Ziva is discovered, built on a decade of research at UWA and the Harry Perkins Institute.

2016

OncoRes Medical is founded in Perth.

Since then

A decade of science and clinical validation, including the MARGIN trial, proving real impact for surgeons and patients.

2026

OncoRes Medical becomes Ziva Surgical: tissue intelligence, where and when it matters most.

What's next

Extending tissue intelligence beyond breast cancer, wherever a surgeon needs to see what they can't otherwise feel.

BORN IN WESTERN AUSTRALIA

Innovation that could 
only come from Perth.

As one of the world's most isolated major cities, Perth innovates because there's no choice. Separated from the rest of the world by thousands of kilometres of ocean and desert, Western Australians have long turned isolation into an advantage: necessity fuelled this state's ingenuity long before anyone called it innovation.

pexels-photo-3556117.avif

The people who built Ziva didn't have the luxury of waiting for someone else to solve the problem in front of them, so they set out to solve it themselves.

And so it is with real‑time tissue assessment, in the moment it matters most. Powered by Ziva. Only in the Elora® System.

Untitled design (5).png

OUR VALUES

Ziva-Icon-Choose-Your-Own-Adventure_1.png

Choose your own adventure

Ziva-Icon-Kind-Hearts.png

Kind Hearts

Ziva-Icon-Teach-Someone-to-Fish.png

Teach someone to fish

Ziva-Icon-Make-Waves.png

Make waves

AT the LAb

“Ziva means light. It names exactly what we do: bring light to what a surgeon cannot otherwise see, in the moment it matters most.”

​

A platform for Tissue Intelligence™, not
just one device

TECHNOLOGY

Elora®, our first system focused on breast cancer, is designed to give surgeons real-time assessment of the tissue inside the surgical cavity – translating the surgeons sense of touch into objective microscale imaging.

Elora® is the first expression of a larger capability we call Tissue Intelligence™. The same science that reads breast tissue today is built to extend further, into other solid cancers, as each is proven through evidence.

Explore Tissue Intelligence™

BUILT ON QME

Quantitative Micro-Elastography, developed over a decade of research at the University of Western Australia and the Harry Perkins Institute of Medical Research. The science is published; Ziva owns the technology built from it.

“Ziva means light. It names exactly what we do: bring light to what a surgeon cannot otherwise see, in the moment it matters most.”

BUILT ON QME

Quantitative Micro-Elastography, developed over a decade of research at the University of Western Australia and the Harry Perkins Institute of Medical Research. The science is published; Ziva owns the technology built from it.

IN THREE STEPS, A RECAP

From a university spin-off
to tissue intelligence.

University spin-off

2013 · UWA & the Harry Perkins Institute

OncoRes Medical

Ziva Surgical

2016 · A decade of science & clinical validation

2026 · Tissue intelligence, at an inflection point

1

2

Ziva means bright, radiant, light: exactly what we're aspiring to bring to the moment a surgeon needs to see what they can't otherwise feel.

3

3

AT the LAb

THE PEOPLE

Built by a small team who show up for the patient, and each other.

Ten years on, the people solving today's problem are still the ones asking what's next. Different backgrounds, one meeting point: medicine, science and engineering.

Meet the team
2026 09 17 - 10 Year Celebration (21).jpg
2026 09 17 - 10 Year Celebration (21).jpg

THE PEOPLE

Built by a team who is driven by what this technology could mean for patients and their families.

Ten years on, the people solving today's problem are still the ones asking what's next. Different backgrounds, one meeting point: medicine, science and engineering.

Meet the team
Explore Tissue Intelligence

See where this story is headed.

From a decade of research, to a platform built to extend

Tissue Intelligence™ into new indications.

Explore Tissue Intelligence™Meet the teamJoin the team
bottom of page